Validation of a quality-of-life instrument for laryngopharyngeal reflux

Archives of Otolaryngology - Head and Neck Surgery

Volumn 131, Issue 4, 2005, Pages 315-320

  Carrau, Ricardo L ^b   Khidr, Aliaa ^c   Gold, Karen F ^d   Crawley, Joseph A ^e   Hillson, Eric M ^a,e   Koufman, Jamie A ^f   Pashos, Chris L ^d  

^a CENTOCOR INC   (United States)

^b UNIVERSITY OF PITTSBURGH MEDICAL CENTER   (United States)

^c UNIVERSITY OF VIRGINIA   (United States)

^d ABT ASSOCIATES   (United States)

^e ASTRAZENECA   (United Kingdom)

^f WAKE FOREST UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

OMEPRAZOLE;

ARTICLE; GASTROESOPHAGEAL REFLUX; HUMAN; LARYNGOPHARYNGEAL REFLUX; MAJOR CLINICAL STUDY; NON INVASIVE MEASUREMENT; QUALITY OF LIFE; QUALITY OF LIFE IN REFLUX AND DYSPEPSIA; SCORING SYSTEM; SHORT FORM 36; UNITED STATES; VOICE HANDICAP INDEX;

ADULT; AGED; AGED, 80 AND OVER; ANTI-ULCER AGENTS; HUMANS; LARYNGEAL DISEASES; MIDDLE AGED; OMEPRAZOLE; PHARYNGEAL DISEASES; PROSPECTIVE STUDIES; QUALITY OF LIFE; QUESTIONNAIRES; REPRODUCIBILITY OF RESULTS;

EID: 17144429775     PISSN: 08864470     EISSN: None     Source Type: Journal    
DOI: 10.1001/archotol.131.4.315     Document Type: Article

References (37)

1. Koufman JA, Aviv JE, Casiano RR, Shaw GY. Laryngopharyngeal reflux: position statement of the Committee on Speech, Voice, and Swallowing Disorders of the American Academy of Otolaryngology-Head and Neck Surgery. Otolaryngol Head Neck Surg. 2002;127:32-35.
2. Koufman JA, Wiener GJ, Wu WC, Castell DO. Reflux laryngitis and its sequelae: the diagnostic role of ambulatory 24-hour pH monitoring. J Voice. 1988;2:78-89.
3. Toohill RJ, Mushtag E, Lehman RH. Otolaryngologic manifestations of gastroesophageal reflux. In: Sacristan T, Alvarez-Vincent JJ, Bartual J, eds. Proceedings of XIV World Congress of Otolaryngology-Head and Neck Surgery. Amsterdam, the Netherlands: Kugler & Ghedini Publications; 1990:3005-3009.
4. Richter JE. Extraesophageal presentations of gastroesophageal reflux disease. Semin Gastrointest Dis. 1997;8:75-89.
5. Koufman J, Sataloff RT, Toohill R. Laryngopharyngeal reflux: consensus conference report. J Voice. 1996;10:215-216.
6. Hawkins BL. Laryngopharyngeal reflux: a modern day "great masquerader". J Ky Med Assoc. 1997;95:379-385.
7. Ahuja V, Yencha MW, Lassen LF. Head and neck manifestations of gastroesophageal reflux disease. Am Fam Physician. 1999;60:873-880.
8. Gaynor EB. Laryngeal complications of GERD. J Clin Gastroenterol. 2000;30:S31-S34.
9. Koufman J. The otolaryngologic manifestations of gastroesophageal reflux disease (GERD). Laryngoscope. 1991;101:1-78.
10. Koufman J. Gastroesophageal reflux and voice disorders. In: Rubin JS, ed. Diagnosis and Treatment of Voice Disorders. New York, NY: Igaku-Shoin; 1995:161-175.
11. Elsen GM, Locke GR, Provenzale D. Health-related quality of life: a primer for gastroenterologists. Am J Gastroenterol. 1999;94:2017-2021.
12. Chassany O, Marquis P, Scherrer B, et al. Validation of a specific quality of life questionnaire for functional digestive disorders. Gut. 1999;44:527-533.
13. Dimenäs E, Glise H, Hallerbäck B, Hernqvist H, Svedlund J, Wkilund I. Quality of life in patients with upper gastrointestinal symptoms: an improved evaluation of treatment regimens? Scand J Gastroenterol. 1993;28:681-687.
14. Wilson IB, Cleary PD. Linking clinical variables with health-related quality of life: a conceptual model of patient outcomes. JAMA. 1995;273:59-65.
15. Revicki DA, Wood M, Maton PN, Sorenson S. The impact of gastroesophageal reflux disease on health-related quality of life. Am J Med. 1998;104:252-258.
16. Yacavone RF, Locke IG, Provenzale DT, Eisen GM. Quality of life measurement in gastroenterology: what is available? Am J Gastroenterol. 2001;96:285-297.
17. Revicki DA, Crawley JA, Zodet MW, Levine DS, Joelsson BO. Complete resolution of heartburn symptoms and health-related quality of life in patients with gastroesophageal reflux disease. Aliment Pharmacol Ther. 1999;13:1621-1630.
18. Mant JW, Jenkinson C, Murphy MF, Clipsham K, Marshall P, Vessey MP. Use of the Short Form-36 to detect the influence of upper gastrointestinal disease on self-reported health status. Qual Life Res. 1998;7:221-226.
19. Rentz AM, Battista C, Trudeau E, et al. Symptom and health-related quality-of life measures for use in selected gastrointestinal disease studies: a review and synthesis of the literature. Pharmaeoeconomics. 2001:19:349-363.
20. Talley NJ, Fullerton S, Junghard O, Wikiund I. Quality of life in patients with endoscopy-negative heartburn. Am J Gastroenterol. 2001;96:1998-2004.
21. Colweil HH, Mathias SD, Pasta DJ, Henning JM, Hunt RH. Development of a health-related quality-of-life questionnaire for individuals with gastroesophageal reflux disease: a validation study. Dig Dis Sci. 1999;44:1376-1383.
22. Wiklund IK, Junghard O, Grace E, et al. Quality of life in reflux and dyspepsia patients: psychometric documentation of a new disease-specific questionnaire (QOLRAD). Eur J Surg Suppl. 1998(583):41-49.
23. Young TL, Kirchdoerfer LJ, Osterhaus JT. A development and validation process for a disease-specific quality of life instrument. Drug Inf J. 1996;30:185-193.
24. Farup C, Kleinman L, Sloan S, et al. The impact of nocturnal symptoms associated with gastroesophageal reflux disease on health-related quality of life. Arch Intern Med. 2001;161:45-52.
25. Revicki DA, Sorensen S, Maton PN, Orlando RC. Health-related quality of life outcomes of omeprazole versus ranitidine in poorly responsive symptomatic gastroesophageal reflux disease. Dig Dis. 1998;16:284-291.
26. Havelund T, Lind T, Wiklund I, et al. Quality of life in patients with heartburn but without esophagitis: effects of treatment with omeprazole. Am J Gastroenterol. 1999;94:1782-1789.
27. Murry T, Rosen CA. Outcome measurements and quality of life in voice disorders. Otolaryngol Clin North Am. 2000;33:905-916.
28. Benninger MS, Ahuja AS, Gardner G, Grywalski C. Assessing outcomes for dysphonic patients. J Voice. 1998;12:540-550.
29. Hogikyan ND, Sethuraman G. Validation of an instrument to measure voice-related quality of life (V-RQOL). J Voice. 1999;13:557-569.
30. Hogikyan ND, Rosen CA. A review of outcome measurements for voice disorders. Otolaryngol Head Neck Surg. 2002;126:562-572.
31. Lenderking WR, Hillson E, Crawley JA, Moore D, Berzon R, Pashos CL. The clinical characteristics and impact of laryngopharyngeal reflux disease on health-related quality of life. Value Health. 2003;6:560-565.
32. Carrau RL, Khidr A, Crawley JA, Hillson EM, Davis JK, Pashos CL. The impact of laryngopharyngeal reflux on patient-reported quality of life. Laryngoscope. In press.
33. Belafsky PC, Postma GN, Koufman JA. The validity and reliability of the reflux finding score. Laryngoscope. 2001;111:1313-1317.
34. McHorney CA, Ware JE, Raczek AE. The MOS 36-item short-form health survery (SF-36), II. Med Care. 1993;31:247-263.
35. Ware JE, Sherbourne CD. The MOS 36-item short-form health survey. Med Care. 1992;30:473-483.
36. Jacobson BH, Johnson A, Grywalski C, et al. The Voice Handicap Index (VHI): development and validation. Am J Speech Lang Pathol. 1997;6:66-70.
37. Jaeschke R, Singer J, Guyatt GH. Measurement of health status. Control Clin Trials. 1989;10:407-415.